AT THE 1991 Annual Meeting, Resolution 259 was referred by the Board of Trustees to the Council on Scientific Affairs (CSA) for a report on the evaluation of the safety of breast implants. The recommendations of Report M prepared by the CSA were adopted as amended by the American Medical Association (AMA) House of Delegates at the Interim Meeting in 1991 in lieu of Resolution 259 (A-91) and Resolution 521 (I-91) and the remainder of the Report was filed (Policy 525.984, AMA Policy Compendium). Report M described the Food and Drug Administration (FDA) regulatory history of breast implant devices through August 1991. Because of continuing developments, including a voluntary moratorium on their use by the FDA in November 1991, the Council elected to provide a follow-up report (Report C) on this subject. Report C covers the continuing FDA regulatory history through October 1992 and
See also pp 2607 and 2608.
Coble YD, Estes EH, Head CA, Karlan MS, Kennedy WR, Numann PJ, Scott WC, Skelton WD, Steinhilber RM, Strong JP, Schneider KA, Wagner HN, Loeb JM, Rinaldi RC, Bennett DR. Silicone Gel Breast Implants. JAMA. 1993;270(21):2602-2606. doi:10.1001/jama.1993.03510210088033